Archives of Clinical Infectious Diseases

Published by: Kowsar

Is Propionibacterium acnes a Causative Agent in Benign Prostate Hyperplasia and Prostate Cancer?

Masoud Dadashi 1 , 2 , Gita Eslami 2 , Afsoon Taghavi 2 , Hossein Goudarzi 2 , Bahareh Hajikhani 2 , * , Mehdi Goudarzi 2 and Mona Ghazi 2
Authors Information
1 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: June 2018, 13 (3); e58947
  • Published Online: June 30, 2018
  • Article Type: Research Article
  • Received: July 27, 2017
  • Revised: December 2, 2017
  • Accepted: December 10, 2017
  • DOI: 10.5812/archcid.58947

To Cite: Dadashi M, Eslami G, Taghavi A, Goudarzi H, Hajikhani B, et al. Is Propionibacterium acnes a Causative Agent in Benign Prostate Hyperplasia and Prostate Cancer?, Arch Clin Infect Dis. 2018 ; 13(3):e58947. doi: 10.5812/archcid.58947.

Abstract
Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 1997;33(7):1075-107. doi: 10.1016/s0959-8049(96)00492-3.
  • 2. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. Cancer J Clin. 2010;60(5):277-300. doi: 10.3322/caac.20073.
  • 3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. doi: 10.1002/ijc.29210. [PubMed: 25220842].
  • 4. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med. 2009;12(1):15-23. [PubMed: 19111024].
  • 5. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med. 2003;349(4):366-81. doi: 10.1056/NEJMra021562. [PubMed: 12878745].
  • 6. Lucas C, Barnich N, Nguyen HTT. Microbiota, Inflammation and Colorectal Cancer. Int J Mol Sci. 2017;18(6). doi: 10.3390/ijms18061310. [PubMed: 28632155]. [PubMed Central: PMC5486131].
  • 7. Sfanos KS, Hempel HA, De Marzo AM. The role of inflammation in prostate cancer. Adv Exp Med Biol. 2014;816:153-81. doi: 10.1007/978-3-0348-0837-8_7. [PubMed: 24818723].
  • 8. McDowell A, Valanne S, Ramage G, Tunney MM, Glenn JV, McLorinan GC, et al. Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol. 2005;43(1):326-34. doi: 10.1128/JCM.43.1.326-334.2005. [PubMed: 15634990]. [PubMed Central: PMC540145].
  • 9. Jakab E, Zbinden R, Gubler J, Ruef C, von Graevenitz A, Krause M. Severe infections caused by Propionibacterium acnes: an underestimated pathogen in late postoperative infections. Yale J Biol Med. 1996;69(6):477-82. [PubMed: 9436290]. [PubMed Central: PMC2589039].
  • 10. Homma JY, Abe C, Chosa H, Ueda K, Saegusa J, Nakayama M, et al. Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med. 1978;48(3):251-5. [PubMed: 713130].
  • 11. Coenye T, Peeters E, Nelis HJ. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res Microbiol. 2007;158(4):386-92. doi: 10.1016/j.resmic.2007.02.001. [PubMed: 17399956].
  • 12. Fredricks DN. Microbial ecology of human skin in health and disease. J Invest Derm Symp P. 2001;6(3):167-9.
  • 13. Hadaway LC. Skin flora and infection. J Infus Nurs. 2003;26(1):44-8. [PubMed: 12544366].
  • 14. Roth RR, James WD. Microbiology of the skin: resident flora, ecology, infection. J Am Acad Dermatol. 1989;20(3):367-90. [PubMed: 2645319].
  • 15. Tacconelli E, Tumbarello M, Pittiruti M, Leone F, Lucia MB, Cauda R, et al. Central venous catheter-related sepsis in a cohort of 366 hospitalised patients. Eur J Clin Microbiol Infect Dis. 1997;16(3):203-9. [PubMed: 9131322].
  • 16. Caputo GM, Archer GL, Calderwood SB, Dinubile MJ, Karchmer AW. Native valve endocarditis due to coagulase-negative staphylococci. Am J Med. 1987;83(4):619-25. doi: 10.1016/0002-9343(87)90889-8.
  • 17. Overturf GD, Sherman MP, Scheifele DW, Wong LC. Neonatal necrotizing enterocolitis associated with delta toxin-producing methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 1990;9(2):88-91. [PubMed: 2314957].
  • 18. Vacheethasanee K, Marchant RE. Surfactant polymers designed to suppress bacterial (Staphylococcus epidermidis) adhesion on biomaterials. J Biomed Mater Res. 2000;50(3):302-12. [PubMed: 10737871].
  • 19. Gronberg H. Prostate cancer epidemiology. Lancet. 2003;361(9360):859-64. doi: 10.1016/S0140-6736(03)12713-4. [PubMed: 12642065].
  • 20. Malvezzi M, Carioli G, Bertuccio P, Rosso T, Boffetta P, Levi F, et al. European cancer mortality predictions for the year 2016 with focus on leukaemias. Ann Oncol. 2016;27(4):725-31. doi: 10.1093/annonc/mdw022. [PubMed: 26812903].
  • 21. Pakzad R, Rafiemanesh H, Ghoncheh M, Sarmad A, Salehiniya H, Hosseini S, et al. Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics. Asian Pac J Cancer Prev. 2016;17(2):839-43. [PubMed: 26925689].
  • 22. Fassi Fehri L, Mak TN, Laube B, Brinkmann V, Ogilvie LA, Mollenkopf H, et al. Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. Int J Med Microbiol. 2011;301(1):69-78. doi: 10.1016/j.ijmm.2010.08.014. [PubMed: 20943438].
  • 23. Nelson JB. Observation for clinically localized prostate cancer. J Clin Oncol. 2014;32(13):1295-8. doi: 10.1200/JCO.2013.54.2043. [PubMed: 24637994].
  • 24. Sfanos KS, Isaacs WB, De Marzo AM. Infections and inflammation in prostate cancer. Am J Clin Exp Urol. 2013;1(1):3-11. [PubMed: 25110720]. [PubMed Central: PMC4219279].
  • 25. Cohen RJ, Shannon BA, McNeal JE, Shannon T, Garrett KL. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J Urol. 2005;173(6):1969-74. doi: 10.1097/01.ju.0000158161.15277.78. [PubMed: 15879794].
  • 26. Alexeyev OA, Marklund I, Shannon B, Golovleva I, Olsson J, Andersson C, et al. Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assay. J Clin Microbiol. 2007;45(11):3721-8. doi: 10.1128/JCM.01543-07. [PubMed: 17881550]. [PubMed Central: PMC2168516].
  • 27. Davidsson S, Molling P, Rider JR, Unemo M, Karlsson MG, Carlsson J, et al. Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer. Infect Agent Cancer. 2016;11:26. doi: 10.1186/s13027-016-0074-9. [PubMed: 27284286]. [PubMed Central: PMC4899914].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments